Term
|
Definition
| drugs that block or inhibit any step of the coagulation process, preventing or slowing clot formation. |
|
|
Term
|
Definition
| drugs that interfere with the aggregation or clumping of platelets to form the platelet plug. |
|
|
Term
|
Definition
| substances formed in the liver – many requiring vitamin K – that react in a cascading sequence to cause the formation of thrombin from prothrombin; thrombin then breaks down fibrin threads from fibrinogen to form a clot.formation of thrombin from prothrombin; thrombin then breaks down fibrin threads from fibrinogen to substances formed in the liver – many requiring vitamin K – that react in a cascading sequence to cause the formation of thrombin from prothrombin; thrombin then breaks down fibrin threads from fibrinogen to form a clot. |
|
|
Term
|
Definition
| cascade of clotting factors in blood that has escaped the vascular system to form a bclot on the outside of the injured vessel. |
|
|
Term
|
Definition
| cascade of clotting factors leading to the formation of a clot within an injured vessel. |
|
|
Term
|
Definition
| property of platelets to adhere to an injured surface and then attract other platelets, which clump together or aggregate at the area, plugging up an injury to the vascular system. |
|
|
Term
|
Definition
| drugs that lyse, or break down, a clot that has formed; these drugs activate the plasminogen mechanism to dissolve fibrin threads. |
|
|
Term
|
Definition
| disorder involving too few red blood cells (RBCs) or ineffective RBCs that can alter the bloods’s ability to carry oxygen. |
|
|
Term
|
Definition
| type of megaloblastic anemia characterized by lack of vitamin B12 secondary to low production of intrinsic factor by gastric cells; vitamin B12 must be replaced by intramuscular injection or nasal spray because it cannot be absorbed through the gastrointestinal tract |
|
|
Term
|
Definition
| anemia caused by lack of vitamin B12 and/or folic acid, in which RBCs are fewer in number and have a weak stroma and a short lifespan; treated by replacement of folic acid and vitamin B12. |
|
|
Term
|
Definition
| low RBC count with low iron available because of high demand, poor diet, or poor absorption; treated with iron replacement. |
|
|
Term
|
Definition
| RBC that has lost its nucleus and entered circulation just recently, not yet fully matured. |
|
|
Term
| Colony stimulating factors |
|
Definition
| are drugs that promote the production of various blood cells. |
|
|
